High levels of antibiotic-resistant pathogens in chickens raised for both meat and eggs on Indian farms are raising serious health concerns for humans, a team of researchers has warned.
The study by researchers from the Centre for Disease Dynamics, Economics and Policy (CDDEP), a public health research organisation with headquarters in Washington DC, and New Delhi, found high levels of antibiotic-resistance on poultry farms in Punjab.
"This study has serious implications, not only for India but globally. Overuse of antibiotics in animal farms endangers all of us," said study author and CDDEP Director Ramanan Laxminarayan.
"We must remove antibiotics from the human food chain, except to treat sick animals, or face the increasingly real prospect of a post-antibiotic world," Laxminarayan added.
Previous CDDEP studies have projected that antibiotic consumption in food animal production will rise globally by 67 per cent by 2030, including more than a tripling of use in India.
For the new study, published in the journal Environmental Health Perspectives on Thursday, researchers collected samples from 530 birds on 18 poultry farms and tested them for resistance to a range of antibiotic medications critical to human medicine.
Two-thirds of the farms reported using antibiotic factors for growth promotion; samples from those farms were three times more likely to be multidrug-resistant than samples from farms that did not use antibiotics to promote growth.
Although the researchers found reservoirs of resistance across both types of farms, meat farms had twice the rates of antimicrobial resistance that egg-producing farms had, as well as higher rates of multidrug resistance.
The CDDEP researchers found high levels of multi-drug resistance, ranging from 39 per cent for ciprofloxacin, used to treat endocarditis, gastroenteritis, cellulitis and respiratory tract infections, and other infections, to 86 percent for nalidixic acid, a common treatment for urinary tract infections.
Additional testing revealed the presence of certain enzymes that confer drug resistance to medications used, for example, to treat E. coli, bacterial pneumonia, and other infections. Almost 60 per cent of E. coli isolates analysed contained these enzymes.
"Use of antibiotics for growth promotion in farm animals has increased worldwide in response to rising demand for food animal products," the team noted.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
